Description: The article gives actuaries an introduction to Academy Health, the notable health policy research organization.

Description: This paper discussed providing consumers of medical care with transparent and comparable price and quality information to enable them to make economically optimal decisions.

Description: News release on Health Care Costs Institute and it's mission to promote research on the causes of rising U.S health spending.

Description: This SOA report describes the components of margin for calculating capitation rates in a Medicaid context along with practical issues that MCOs may face.

Description: Health Care Cost Trends 2002 - prescription drug, base and leveraged trend. From Health Section News, January 2002, Issue No. 42.

Description: This article discusses Accountable Care Organizations, how they work, managing risks and their expectations to bend the cost curve.

Description: Physicians and hospital representatives will discuss their views on health care reform, insurance companies and managed care. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session discusses affordable health care including cost drivers, trends, the uninsured, federal funding and state initiatives. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 109

Description: This session from the 2003 SOA Orlando Meeting presents various predictive models, evaluation methodologies, control groups, current and potential uses for predictive modeling and issues surrounding implementation of a predictive modeling process. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.